# OnCo record paper-conko-001-adjuvant-gemcitabine-long-term-oettle-jama-2013 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-conko-001-adjuvant-gemcitabine-long-term-oettle-jama-2013/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-conko-001-adjuvant-gemcitabine-long-term-oettle-jama-2013" ;
  schema:name "CONKO-001: adjuvant gemcitabine and long-term outcomes after resected pancreatic cancer"@en ;
  schema:description "Six months of gemcitabine after complete removal of pancreatic cancer doubled the time to relapse and roughly doubled five-year survival, from 10 to 21 percent, in the trial that established adjuvant chemotherapy for the disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-conko-001-adjuvant-gemcitabine-long-term-oettle-jama-2013/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jama.2013.279201>, <https://pubmed.ncbi.nlm.nih.gov/24104372/> ;
  schema:sameAs <https://doi.org/10.1001/jama.2013.279201> ;
  schema:datePublished "2013"^^xsd:gYear ;
  schema:author "Oettle H, Neuhaus P, Hochhaus A, et al." ;
  onco:cancers <https://onco.cc/cancers/resectable-pdac/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine/> ;
  onco:trials <https://onco.cc/trials/conko-001/> ;
  onco:journals <https://onco.cc/journals/jama/> .